Medicare Enrolled
Dr. Todd Gersten, M.D.
Hematology · Wellington, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gersten from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gersten? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gersten
Dr. Todd Gersten is a hematology in Wellington, FL, with 20 years in practice. Based on federal Medicare data, Dr. Gersten performed 88,033 Medicare services across 3,353 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gersten received a total of $36,757 from 112 pharmaceutical and/or device companies across 1790 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gersten is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 48% volume in FL$ $36,757 industry payments
Medicare Practice Summary
Medicare Utilization ↗88,033
Medicare services
Top 48% in FL for hematology
3,353
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,402 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Paclitaxel chemotherapy injection | 12,075 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 11,700 | $1 | $5 |
| Pembrolizumab injection (Keytruda) | 10,800 | $43 | $137 |
| Contrast dye for imaging (iodine-based) | 10,655 | $0 | $1 |
| Iron infusion (Feraheme) | 8,160 | $0 | $4 |
| Iron sucrose injection (Venofer) | 8,000 | $0 | $5 |
| Iron infusion (Monoferric) | 5,600 | $16 | $57 |
| Denosumab injection (Prolia/Xgeva) | 4,620 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 3,880 | $6 | $23 |
| Dexamethasone injection (steroid) | 2,339 | $0 | $3 |
| Blood draw (venipuncture) | 1,598 | $8 | $9 |
| Complete blood count (CBC) with differential | 1,524 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,320 | $1 | $28 |
| Office visit, established patient (20-29 min) | 848 | $69 | $239 |
| Anti-nausea injection (ondansetron/Zofran) | 560 | $0 | $9 |
| Injection of additional new drug or substance into vein | 522 | $12 | $61 |
| Drug injection, under skin or into muscle | 482 | $11 | $69 |
| Administration of chemotherapy into vein, 1 hour or less | 446 | $103 | $378 |
| Office visit, established patient (30-39 min) | 412 | $99 | $339 |
| Injection, carboplatin, 50 mg | 306 | $2 | $41 |
| Injection, zoledronic acid, 1 mg | 211 | $7 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 208 | $49 | $189 |
| Injection, diphenhydramine hcl, up to 50 mg | 162 | $1 | $3 |
| Administration of chemotherapy into vein, each additional hour | 142 | $22 | $79 |
| Administration of additional new drug or substance into vein, 1 hour or less | 130 | $51 | $178 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 123 | $23 | $84 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 112 | $1,157 | $3,709 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 112 | $397 | $680 |
| CT scan of abdomen and pelvis with contrast | 95 | $180 | $550 |
| Ct scan of chest with contrast | 93 | $54 | $344 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 84 | $137 | $562 |
| Infusion into a vein for hydration, each additional hour | 74 | $10 | $42 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 55 | $16 | $56 |
| Infusion, normal saline solution , 1000 cc | 51 | $2 | $7 |
| New patient office visit (45-59 min) | 48 | $124 | $453 |
| Office visit, established patient, complex (40-54 min) | 46 | $139 | $474 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 43 | $1 | $6 |
| Automated urinalysis | 39 | $2 | $8 |
| Infusion into a vein for hydration, 31-60 minutes | 35 | $26 | $156 |
| New patient office visit (30-44 min) | 35 | $84 | $298 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 33 | $26 | $89 |
| Administration of additional new drug or substance into vein using push technique | 33 | $45 | $170 |
| New patient office visit, complex (60-74 min) | 32 | $171 | $585 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 32 | $3 | $11 |
| Initial hospital admission, moderate complexity | 28 | $107 | $377 |
| CT scan of chest, without contrast | 25 | $59 | $350 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 23 | $19 | $59 |
| Hospital follow-up visit, moderate complexity | 20 | $65 | $197 |
| Transitional care management services for problem of high complexity | 14 | $223 | $722 |
| Red blood count automated, with additional calculations | 12 | $5 | $20 |
| Injection of drug or substance into vein | 12 | $27 | $156 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 12 | $69 | $281 |
| Initial hospital admission, high complexity | 12 | $142 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
16.3% high complexity
78.0% medium
5.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$36,757
Total received (2018-2024)
Avg $5,251/year across 7 years
Top 12% in FL for hematology
112
Companies
1,790
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$29,563 (80.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,089 (16.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$795 (2.2%)
Other
Charitable contributions, space rental, and other categories
$309 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,260
2023$5,196
2022$4,614
2021$3,965
2020$3,902
2019$4,811
2018$9,009
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,042
Novocure Inc.
$1,834
PFIZER INC.
$1,821
Novartis Pharmaceuticals Corporation
$1,817
E.R. Squibb & Sons, L.L.C.
$1,785
Puma Biotechnology, Inc.
$1,709
Janssen Biotech, Inc.
$1,674
Bayer HealthCare Pharmaceuticals Inc.
$1,562
Celgene Corporation
$1,372
GlaxoSmithKline, LLC.
$1,136
Genentech USA, Inc.
$1,114
Amgen Inc.
$1,077
Astellas Pharma US Inc
$1,008
GENZYME CORPORATION
$970
Incyte Corporation
$937
Lilly USA, LLC
$928
Seagen Inc.
$881
Merck Sharp & Dohme LLC
$804
Merck Sharp & Dohme Corporation
$659
Daiichi Sankyo Inc.
$619
Takeda Pharmaceuticals U.S.A., Inc.
$617
Eisai Inc.
$455
Blueprint Medicines Corporation
$444
Ipsen Biopharmaceuticals, Inc
$399
NanoString Technologies, Inc.
$359
ABBVIE INC.
$351
Janssen Scientific Affairs, LLC
$350
Alexion Pharmaceuticals, Inc.
$310
NOVARTIS PHARMACEUTICALS CORPORATION
$309
Boehringer Ingelheim Pharmaceuticals, Inc.
$289
Foundation Medicine, Inc.
$280
Regeneron Healthcare Solutions, Inc.
$260
Pharmacyclics LLC, An AbbVie Company
$238
Seattle Genetics, Inc.
$225
JAZZ PHARMACEUTICALS INC.
$225
Adaptive Biotechnologies Corporation
$217
EISAI INC.
$208
Dova Pharmaceuticals
$201
Rigel Pharmaceuticals, Inc.
$198
Kite Pharma, Inc.
$187
Clovis Oncology, Inc.
$177
EMD Serono, Inc.
$173
Exelixis Inc.
$173
Gilead Sciences, Inc.
$165
TESARO, Inc.
$157
COMSORT, Inc
$150
Dendreon Pharmaceuticals LLC
$149
ARRAY BIOPHARMA INC
$148
Spectrum Pharmaceuticals Inc.
$127
SOBI, INC
$127
Aurobindo Pharma USA, Inc.
$127
BeiGene USA, Inc.
$126
Myriad Genetic Laboratories, Inc.
$123
Agios Pharmaceuticals, Inc.
$118
Heron Therapeutics, Inc.
$106
AVEO Pharmaceuticals, Inc.
$105
Bayer Healthcare Pharmaceuticals Inc.
$105
AbbVie, Inc.
$103
MorphoSys, US Inc.
$103
Taiho Oncology, Inc.
$99
Sirtex Medical Inc
$99
Menarini Silicon Biosystems, Inc.
$98
Kyowa Kirin, Inc.
$97
Karyopharm Therapeutics Inc.
$80
Shire North American Group Inc
$75
SERVIER PHARMACEUTICALS LLC
$73
Sobi, Inc
$73
Mirati Therapeutics, Inc.
$72
Pharmacyclics LLC, an AbbVie Company
$68
TAIHO ONCOLOGY, INC.
$67
AbbVie Inc.
$66
Aveo Pharmaceuticals, Inc.
$65
Lexicon Pharmaceuticals, Inc.
$61
Janssen Pharmaceuticals, Inc
$61
Shield Therapeutics Inc
$59
MEDIVATION FIELD SOLUTIONS LLC
$52
PUMA BIOTECHNOLOGY, INC.
$51
Pharmacosmos Therapeutics Inc.
$49
Servier Pharmaceuticals LLC
$48
Helsinn Therapeutics (U.S.), Inc.
$47
TerSera Therapeutics LLC
$45
Sun Pharmaceutical Industries Inc.
$43
Otsuka America Pharmaceutical, Inc.
$42
Deciphera Pharmaceuticals Inc.
$42
SUN PHARMACEUTICAL INDUSTRIES INC.
$41
CTI BioPharma Corp.
$41
G1 Therapeutics, Inc.
$39
Acceleron Pharma, Inc.
$38
Medtronic, Inc.
$37
SANOFI-AVENTIS U.S. LLC
$37
Blue Earth Diagnostics Limited
$32
Verastem, Inc.
$31
Emmaus Medical, Inc.
$31
Napo Pharmaceuticals Inc
$29
PharmaEssentia USA Corporation
$27
Genmab U.S., Inc.
$26
Secura Bio, Inc.
$24
Coherus Biosciences Inc.
$23
Legend Biotech USA Inc.
$22
Jazz Pharmaceuticals Inc.
$22
Partner Therapeutics, Inc.
$20
Cumberland Pharmaceuticals, Inc.
$20
Immunocore Limited
$20
ADC Therapeutics America, Inc.
$20
ImmunoGen, Inc.
$19
TG THERAPEUTICS, INC.
$17
Global Blood Therapeutics, Inc.
$16
Array BioPharma Inc.
$16
EUSA Pharma (US) LLC
$16
Teva Pharmaceuticals USA, Inc.
$11
Advanced Accelerator Applications
$11
Veracyte, Inc.
$6
Top 3 companies account for 15.5% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · ASPARLAS · AUGTYRO · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cellsearch · Cinvanti · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · Elahere · Endari · Enhertu · Epkinly · FARESTON · FASENRA · FASLODEX · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAMMAGARD · GAUCHER-DISEASE · GAVRETO · GAZYVA · GELCLAIR CONCENTRATED ORAL GEL · GILOTRIF · Halaven · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LEUKINE · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCREVUS · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION SYSTEM · OXBRYTA · Odomzo · Oncology · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POSLUMA · POTELIGEO · PRECISETUMOR · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VONVENDI · VOTRIENT · VPRIV · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · YONSA (abiraterone acetate) · Yescarta · ZEJULA · ZEPZELCA · ZYKADIA · ZYTIGA · Zevalin · Zoladex · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $42 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
11
Per 100K population
0.7
County median income
$81,115
Nearest hospital
WELLINGTON REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gersten is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 12%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gersten experienced with paclitaxel chemotherapy injection?
Based on Medicare claims data, Dr. Gersten performed 12,075 paclitaxel chemotherapy injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gersten receive payments from pharmaceutical companies?
Yes. Dr. Gersten received a total of $36,757 from 112 companies across 1,790 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gersten's costs compare to other hematologys in Wellington?
Dr. Gersten's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gersten) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Wellington
Browse hematologys in Wellington ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novocure Inc. Payments to Doctors
See all physicians who received payments from Novocure Inc..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology